Red Cell Metabolism Notes
Glycolysis
Glycolysis is the primary catabolic pathway for the breakdown of glucose into pyruvate, generating two molecules of ATP in the process. It takes place in the cytoplasm of red blood cells (RBCs) and involves multiple enzymatic reactions that are essential for energy production.
ATP is required for various critical functions in red blood cells:
Maintenance of red cell shape: It ensures the integrity and flexibility of the cell membrane, essential for the passage of red blood cells through narrow capillaries.
Operation of the sodium-potassium pump: This pump maintains the osmotic balance within the cells by regulating the concentration of sodium and potassium ions, preventing swelling or shrinking of cells.
Regeneration of NAD+, which is crucial for glycolytic processes to continue.
Steps of Glycolysis:
Glucose is converted to glucose 6-phosphate through the action of hexokinase, consuming one ATP molecule in the process.
Glucose 6-phosphate is rearranged into fructose 6-phosphate, facilitated by phosphoglucose isomerase.
Fructose 6-phosphate is phosphorylated to form fructose 1,6-bisphosphate, requiring another ATP.
Fructose 1,6-bisphosphate is cleaved into two three-carbon molecules of glyceraldehyde 3-phosphate (G3P).
Glyceraldehyde 3-phosphate is converted to 1,3-bisphosphoglycerate, producing NADH through the reduction of NAD+. This step is catalyzed by glyceraldehyde 3-phosphate dehydrogenase.
1,3-bisphosphoglycerate is converted to 3-phosphoglycerate, generating ATP via substrate-level phosphorylation through phosphoglycerate kinase.
3-phosphoglycerate is converted to 2-phosphoglycerate under the action of phosphoglycerate mutase.
2-phosphoglycerate is dehydrated to phosphoenolpyruvate (PEP) by enolase.
Phosphoenolpyruvate is converted to pyruvate, generating another ATP molecule through pyruvate kinase.
Overall, the stoichiometric equation summarizing glycolysis is:
NAD+ Regeneration
To sustain glycolysis, NAD+ must be regenerated. This occurs through the conversion of pyruvate to lactate via lactate dehydrogenase, especially when oxygen levels are low (anaerobic conditions).
2,3-Biphosphoglycerate (2,3-BPG)
2,3-BPG is a crucial molecule in red blood cell metabolism that facilitates the release of oxygen from hemoglobin to the tissues. It acts as an allosteric modulator that decreases hemoglobin's affinity for oxygen, enhancing oxygen delivery.
Synthesis of 2,3-BPG
The synthesis of 2,3-BPG occurs via the Rapoport-Luebering glycolytic shunt:
1,3-bisphosphoglycerate is converted to 2,3-bisphosphoglycerate by bisphosphoglycerate mutase.
2,3-BPG can then be dephosphorylated to form 3-phosphoglycerate by the action of 2,3-bisphosphoglycerate phosphatase.
Role of 2,3-BPG
Binds specifically to the beta chains (lysine 82 and histidine residues) of deoxygenated hemoglobin.
Reduces hemoglobin's affinity for oxygen, promoting release in tissues with high metabolic activity.
Fetal hemoglobin (HbF) has lower binding affinity for 2,3-BPG compared to adult hemoglobin (HbA), resulting in higher affinity for oxygen necessary for effective oxygen transfer from mother to fetus.
Hemoglobin and Oxygen
Function of Hemoglobin
The primary role of hemoglobin is to transport oxygen from the lungs to the tissues. Each hemoglobin molecule is composed of four heme groups and four polypeptide chains (two alpha and two beta chains). The hydrophobic environment of the heme pocket allows oxygen to bind effectively.
Oxygenation Mechanism
When oxygen binds to heme iron (Fe2+), a change occurs in the electron distribution, causing:
Movement of iron into the plane of the heme ring.
This movement pulls the F8 histidine, inducing a conformational change at the alpha1-beta2 contact point.
This conformational change facilitates cooperative binding, allowing subsequent oxygen molecules to bind more easily.
Oxygen Saturation Curve
The curve depicts the saturation of hemoglobin in relation to varying partial pressures of oxygen (PO2). Oxygenated blood leaving the lungs showcases high saturation, while deoxygenated blood returning from tissues exhibits lower saturation levels.
Bohr Effect
The Bohr effect describes how certain physiological conditions can shift the hemoglobin-oxygen saturation curve:
Impact of pH:
A decrease in pH (increase in hydrogen ion concentration) results in lower oxygen affinity (right shift).
High pH leads to increased affinity (left shift).
Impact of 2,3-BPG: This compound leads to a decreased affinity of HbA for oxygen, further shifting the curve rightward.
Oxygen Affinity in Lungs vs. Tissues
In the Lungs:
High oxygen affinity due to high PO2 and low PCO2.
In the Tissues:
Lower oxygen affinity due to low PO2 and high PCO2, facilitating oxygen delivery.
Pentose Phosphate Shunt
This pathway generates five-carbon sugars and is essential for protecting red blood cells against oxidative damage.
Oxidants
Superoxide and hydrogen peroxide are two key oxidants. If they are not controlled, they can lead to oxidation of hemoglobin, resulting in the formation of Heinz bodies.
Heinz Bodies
These are formed through the oxidation of heme iron to Fe3+, leading to denaturation of globin chains. Notable conditions associated with Heinz body formation include G-6-PD deficiency and treatment with primaquine.
Defenses against Oxidants
Superoxide dismutase (SOD): Catalyzes the conversion of superoxide into molecular oxygen and hydrogen peroxide.
Catalase: Breaks down hydrogen peroxide into water and oxygen.
Glutathione Peroxidase: Uses NADPH to reduce hydrogen peroxide, converting it to water and oxidized glutathione.
Glucose-6-Phosphate Dehydrogenase
Glutathione
Hemoglobin Protection
Ferrous iron in hemoglobin can oxidize to ferric iron (Fe3+), particularly in the presence of nitrite ions. Methemoglobin can be converted back to hemoglobin through the action of methemoglobin reductase, allowing the resumption of oxygen transport.
Summary
Role of glycolysis in ATP production and maintaining red blood cell function.
Bohr Effect dynamics regarding pH and 2,3-BPG.
The significance of protective mechanisms against oxidative damage in red blood cells.